The anti-DNA antibody: Origin and impact, dogmas and controversies

Nature Reviews Rheumatology

Volumn 11, Issue 9, 2015, Pages 530-540

  Rekvig, Ole P ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

DNA ANTIBODY; DNA NUCLEOTIDYLEXOTRANSFERASE; DOUBLE STRANDED DNA; IMMUNOGLOBULIN G; AUTOANTIBODY; DNA;

CLINICAL MEDICINE; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOLOGY; LUPUS ERYTHEMATOSUS NEPHRITIS; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; VIRUS REPLICATION; ANIMAL; GENETICS;

ANIMALS; AUTOANTIBODIES; DNA; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC;

EID: 84940601299     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2015.69     Document Type: Review

References (122)

1. Menzel, A. E. O. & Heidelberger, M. Cell protein fractions of bovine and avian tubercle bacillus strains and of the timothy-grass bacillus. J. Biol. Chem. 124, 301-307 (1938).
2. Sevag, M. G., Lackman, D. B. & Smolen, J. The isolation of the components of streptococcal nucleoproteins in serologically active form. J. Biol. Chem. 124, 425-436 (1938).
3. Winkenwerder, W. L., Buell, M. V. & Howard, J. E. The sensitizing properties of the nucleic acids and their derivatives. Science 90, 356 (1939).
4. Ceppellini, R., Polli, E. & Celada, F. A DNA-reacting factor in serum of a patient with lupus erythematosus diffusus. Proc. Soc. Exp. Biol. Med. 96, 572-574 (1957).
5. Robbins, W. C., Holman, H. R., Deicher, H. & Kunkel, H. G. Complement fixation with cell nuclei and DNA in lupus erythematosus. Proc. Soc. Exp. Biol. Med. 96, 575-579 (1957).
6. Miescher, P. & Strassle, R. New serological methods for the detection of the L. E. factor. Vox Sang. 2, 283-287 (1957).
7. Seligman, M. Serology-evidence in serum from patients with disseminated lupus erythermatosus of a substance determining a precipitation reac tion with desoxyribonucleic acid [French]. C. R. Hebd. Seances Acad. Sci. 245, 243-245 (1957).
8. Stollar, B. D. Immunochemistry of DNA. Int. Rev. Immunol. 5, 1-22 (1989).
9. Stollar, B. D. Antibodies to DNA. CRC Crit. Rev. Biochem. 20, 1-36 (1986).
10. Madaio, M. P., Hodder, S., Schwartz, R. S. & Stollar, B. D. Responsiveness of autoimmune and normal mice to nucleic acid antigens. J. Immunol. 132, 872-876 (1984).
11. Pisetsky, D. S. & Vrabie, I. A. Antibodies to DNA: infection or genetics? Lupus 18, 1176-1180 (2009).
12. Lafer, E. M. et al. Polyspecific monoclonal lupus autoantibodies reactive with both polynucleotides and phospholipids. J. Exp. Med. 153, 897-909 (1981).
13. Mostoslavsky, G. et al. Lupus anti-DNA autoantibodies crossreact with a glomerular structural protein: a case for tissue injury by molecular mimicry. Eur. J. Immunol. 31, 1221-1227 (2001).
14. Putterman, C. & Diamond, B. Immunization with a peptide surrogate for double-stranded DNA (dsDNA) induces autoantibody production and renal immunoglobulin deposition. J. Exp. Med. 188, 29-38 (1998).
15. DeGiorgio, L. A. et al. A subset of lupus anti-DNA antibodies crossreacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat. Med. 7, 1189-1193 (2001).
16. Stollar, B. D. Why the difference between B-DNA and Z-DNA? Lupus 6, 327-328 (1997).
17. Shlomchik, M. et al. Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation. J. Exp. Med. 171, 265-292 (1990).
18. Marion, T. N., Krishnan, M. R., Steeves, M. A. & Desai, D. D. Affinity maturation and autoimmunity to DNA. Curr. Dir. Autoimmun. 6, 123-153 (2003).
19. Radic, M. Z. & Weigert, M. Genetic and structural evidence for antigen selection of anti-DNA antibodies. Annu. Rev. Immunol. 12, 487-520 (1994).
20. Desai, D. D., Krishnan, M. R., Swindle, J. T. & Marion, T. N. Antigen-specific induction of antibodies against native mammalian DNA in nonautoimmune mice. J. Immunol. 151, 1614-1626 (1993).
21. Rekvig, O. P., Bendiksen, S. & Moens, U. Immunity and autoimmunity induced by polyomaviruses: clinical, experimental and theoretical aspects. Adv. Exp. Med. Biol. 577, 117-147 (2006).
22. Rekvig, O. P. Anti-dsDNA antibodies as a classification criterion and a diagnostic marker for SLE: critical remarks. Clin. Exp. Immunol. 179, 5-10 (2014).
23. Compagno, M. et al. Low diagnostic and predictive value of anti-dsDNA antibodies in unselected patients with recent onset of rheumatic symptoms: results from a long-Term follow-up Scandinavian multicentre study. Scand. J. Rheumatol. 42, 311-316 (2013).
24. Krishnan, M. R., Wang, C. & Marion, T. N. Anti-DNA autoantibodies initiate experimental lupus nephritis by binding directly to the glomerular basement membrane in mice. Kidney Int. 82, 184-192 (2012).
25. Seredkina, N., van der Vlag, J., Berden, J., Mortensen, E. & Rekvig, O. P. Lupus nephritis: enigmas, conflicting models and an emerging concept. Mol. Med. 19, 161-169 (2013).
26. Pisetsky, D. S. The role of innate immunity in the induction of autoimmunity. Autoimmun. Rev. 8, 69-72 (2008).
27. Krieg, A. M. & Vollmer, J. Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity. Immunol. Rev. 220, 251-269 (2007).
28. Medzhitov, R. & Janeway, C. A. Jr. Decoding the patterns of self and nonself by the innate immune system. Science 296, 298-300 (2002).
29. Christensen, S. R. & Shlomchik, M. J. Regulation of lupus-related autoantibody production and clinical disease by Toll-like receptors. Semin. Immunol. 19, 11-23 (2007).
30. Schwartz, R. H. T cell clonal anergy. Curr. Opin. Immunol. 9, 351-357 (1997).
31. Foster, M. H. T cells and B cells in lupus nephritis. Semin. Nephrol. 27, 47-58 (2007).
32. Matzinger, P. The danger model: a renewed sense of self. Science 296, 301-305 (2002).
33. Sandel, P. C. & Monroe, J. G. Negative selection of immature B cells by receptor editing or deletion is determined by site of antigen encounter. Immunity 10, 289-299 (1999).
34. Ehrlich, P. &, Morgenroth, J. Ueber Haemolysine: dritte Mittheilung [German]. Berlin Klin. Wochenschr. 37, 453-458 (1900).
35. Ehrlich, P. Ueber Hämolysine: fünfte Mittheilung [German]. Berlin Klin. Wochenschr. 38, 251-257 (1901).
36. Silverstein, A. M. Autoimmunity versus horror autotoxicus: the struggle for recognition. Nat. Immunol. 2, 279-281 (2001).
37. Blix, U., Iland, C. N. & Stacey, M. The serological activity of desoxypentosenucleic acids. Br. J. Exp. Pathol. 35, 241-251 (1954).
38. Krieg, A. M. et al. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374, 546-549 (1995).
39. Yamamoto, S. et al. Unique palindromic sequences in synthetic oligonucleotides are required to induce IFN [correction of INF] and augment IFN-mediated [correction of INF] natural killer activity. J. Immunol. 148, 4072-4076 (1992).
40. Klinman, D. M., Yi, A. K., Beaucage, S. L., Conover, J. & Krieg, A. M. CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma. Proc. Natl Acad. Sci. USA 93, 2879-2883 (1996).
41. Sato, Y. et al. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 273, 352-354 (1996).
42. Rock, K. L., Benacerraf, B. & Abbas, A. K. Antigen presentation by hapten-specific B lymphocytes. I. Role of surface immunoglobulin receptors. J. Exp. Med. 160, 1102-1113 (1984).
43. Sundar, K. et al. Expression of the Epstein-Barr virus nuclear antigen-1 (EBNA-1) in the mouse can elicit the production of anti-dsDNA and anti-Sm antibodies. J. Autoimmun. 23, 127-140 (2004).
44. Cerutti, M. L., Zarebski, L. M., de Prat, G. G. & Goldbaum, F. A. A viral DNA-binding domain elicits anti-DNA antibodies of different specificities. Mol. Immunol. 42, 327-333 (2005).
45. Moens, U. et al. In vivo expression of a single viral DNA-binding protein generates systemic lupus erythematosus-related autoimmunity to double-stranded DNA and histones. Proc. Natl Acad. Sci. USA 92, 12393-12397 (1995).
46. Van Ghelue, M., Moens, U., Bendiksen, S. & Rekvig, O. P. Autoimmunity to nucleosomes related to viral infection: a focus on hapten-carrier complex formation. J. Autoimmun. 20, 171-182 (2003).
47. Edgington, S. M. & Stollar, B. D. Immunogenicity of Z-DNA depends on the size of polynucleotide presented in complexes with methylated BSA. Mol. Immunol. 29, 609-617 (1992).
48. Rekvig, O. P. & Nossent, J. C. Anti-double-stranded DNA antibodies, nucleosomes, and systemic lupus erythematosus: a time for new paradigms? Arthritis Rheum. 48, 300-312 (2003).
49. Biermann, M. H. et al. The role of dead cell clearance in the aetiology and pathogenesis of systemic lupus erythematosus: dendritic cells as potential targets. Expert. Rev. Clin. Immunol. 10, 1151-1164 (2014).
50. Fenton, K. The effect of cell death in the initiation of lupus nephritis. Clin. Exp. Immunol. 179, 11-16 (2015).
51. Schroeder, K., Herrmann, M. & Winkler, T. H. The role of somatic hypermutation in the generation of pathogenic antibodies in SLE. Autoimmunity 46, 121-127 (2013).
52. Ghosh, A. & Bansal, M. A glossary of DNA structures from A to Z. Acta Crystallogr. D. Biol. Crystallogr. 59, 620-626 (2003).
53. Ha, S. C., Lowenhaupt, K., Rich, A., Kim, Y. G. & Kim, K. K. Crystal structure of a junction between B-DNA and Z-DNA reveals two extruded bases. Nature 437, 1183-1186 (2005).
54. Rothenburg, S., Koch-Nolte, F. & Haag, F. DNA methylation and Z.-DNA formation as mediators of quantitative differences in the expression of alleles. Immunol. Rev. 184, 286-298 (2001).
55. Rekvig, O. P. et al. Experimental expression in mice and spontaneous expression in human SLE of polyomavirus T-Antigen. A molecular basis for induction of antibodies to DNA and eukaryotic transcription factors. J. Clin. Invest. 99, 2045-2054 (1997).
56. Hahn, B. H. Antibodies to DNA. N. Engl. J. Med. 338, 1359-1368 (1998).
57. Tan, E. M. et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25, 1271-1277 (1982).
58. Petri, M. et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 64, 2677-2686 (2012).
59. Widom, J. A relationship between the helical twist of DNA and the ordered positioning of nucleosomes in all eukaryotic cells. Proc. Natl Acad. Sci. USA 89, 1095-1099 (1992).
60. Richmond, T. J. & Davey, C. A. The structure of DNA in the nucleosome core. Nature 423, 145-150 (2003).
61. Griffith, J., Bleyman, M., Rauch, C. A., Kitchin, P. A. & Englund, P. T. Visualization of the bent helix in kinetoplast DNA by electron microscopy. Cell 46, 717-724 (1986).
62. Stollar, B. D. The experimental induction of antibodies to nucleic acids. Methods Enzymol. 70, 70-85 (1980).
63. Isenberg, D. A., Manson, J. J., Ehrenstein, M. R. & Rahman, A. Fifty years of anti-dsDNA antibodies: are we approaching journey's end? Rheumatology (Oxford) 46, 1052-1056 (2007).
64. Amital, H. et al. Treatment with a laminin-derived peptide suppresses lupus nephritis. J. Immunol. 175, 5516-5523 (2005).
65. Wellmann, U. et al. The evolution of human anti-double-stranded DNA autoantibodies. Proc. Natl Acad. Sci. USA 102, 9258-9263 (2005).
66. Olins, A. L. & Olins, D. E. Spheroid chromatin units (v bodies). Science 183, 330-332 (1974).
67. Kornberg, R. D. & Lorch, Y. Twenty-five years of the nucleosome, fundamental particle of the eukaryote chromosome. Cell 98, 285-294 (1999).
68. Luger, K., Mader, A. W., Richmond, R. K., Sargent, D. F. & Richmond, T. J. Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 389, 251-260 (1997).
69. de Graaf, C. A. & van Stenseel, B. Chromatin organization: form to function. Curr. Opin. Genet. Dev. 23, 185-190 (2013).
70. van Steensel, B. Chromatin: constructing the big picture. EMBO J. 30, 1885-1895 (2011).
71. Woodcock, C. L. & Ghosh, R. P. Chromatin higher-order structure and dynamics. Cold Spring Harb. Perspect. Biol. 2, a000596 (2010).
72. Haugbro, K., Nossent, J. C., Winkler, T., Figenschau, Y. & Rekvig, O. P. Anti-dsDNA antibodies and disease classification in antinuclear antibody positive patients: the role of analytical diversity. Ann. Rheum. Dis. 63, 386-394 (2004).
73. Compagno, M. et al. Clinical phenotype associations with various types of anti-dsDNA antibodies in patients with recent onset of rheumatic symptoms. Results from a multicentre observational study. Lupus Sci. Med. 1, e000007 (2014).
74. Neogi, T., Gladman, D. D., Ibanez, D. & Urowitz, M. Anti-dsDNA antibody testing by Farr and ELISA techniques is not equivalent. J. Rheumatol. 33, 1785-1788 (2006).
75. Rekvig, O. P., van der Vlag, J. & Seredkina, N. Anti-nucleosome antibodies-A critical reflection on their specificities and diagnostic impact. Arthritis Rheumatol. 66, 1061-1069 (2014).
76. Marion, T. N. et al. Immunoglobulin variable-region structures in immunity and autoimmunity to DNA. Tohoku J. Exp. Med. 173, 43-63 (1994).
77. Williams, R. C. Jr, Malone, C. C., Meyers, C., Decker, P. & Muller, S. Detection of nucleosome particles in serum and plasma from patients with systemic lupus erythematosus using monoclonal antibody 4H7. J. Rheumatol. 28, 81-94 (2001).
78. Kramers, K. et al. Specificity of monoclonal anti-nucleosome auto-Antibodies derived from lupus mice. J. Autoimmun. 9, 723-729 (1996).
79. Stemmer, C., Briand, J. P. & Muller, S. Mapping of linear histone regions exposed at the surface of the nucleosome in solution. J. Mol. Biol. 273, 52-60 (1997).
80. Lenschow, D. J., Walunas, T. L. & Bluestone, J. A. CD28/B7 system of T cell co-stimulation. Annu. Rev. Immunol. 14, 233-258 (1996).
81. Voll, R. E. et al. Histone-specific TH0 and TH1 clones derived from systemic lupus erythematosus patients induce double-stranded DNA antibody production. Arthritis Rheum. 40, 2162-2171 (1997).
82. Datta, S. K. Production of pathogenic antibodies: cognate interactions between autoimmune T and B cells. Lupus. 7, 591-596 (1998).
83. Rekvig, O. P. et al. Molecular analyses of anti-DNA antibodies induced by polyomavirus BK in BALB/c mice. Scand. J. Immunol. 41, 593-602 (1995).
84. Craft, J. E. & Hardin, J. A. Linked sets of antinuclear antibodies: what do they mean? J. Rheumatol. Suppl. 14 (Suppl. 13), 106-109 (1987).
85. Radic, M., Herrmann, M., van der Vlag, J. & Rekvig, O. P. Regulatory and pathogenetic mechanisms of autoantibodies in SLE. Autoimmunity 44, 349-356 (2011).
86. Munoz, L. E., Lauber, K., Schiller, M., Manfredi, A. A. & Herrmann, M. The role of defective clearance of apoptotic cells in systemic autoimmunity. Nat. Rev. Rheumatol. 6, 280-289 (2010).
87. Andreassen, K., Moens, U., Nossent, H., Marion, T. N. & Rekvig, O. P. Termination of human T cell tolerance to histones by presentation of histones and polyomavirus T-Antigen provided that T-Antigen is complexed with nucleosomes. Arthritis Rheum. 42, 2449-2460 (1999).
88. Andreassen, K. et al. T cell autoimmunity to histones and nucleosomes is a latent property of the normal immune system. Arthritis Rheum. 46, 1270-1281 (2002).
89. Jenkins, M. K. The role of cell division in the induction of clonal anergy. Immunol. Today 13, 69-73 (1992).
90. Dure, M. & Macian, F. IL-2 signalling prevents T cell anergy by inhibiting the expression of anergy-inducing genes. Mol. Immunol. 46, 999-1006 (2009).
91. Rekvig, O. P. & van der Vlag, J., The pathogenesis and diagnosis of systemic lupus erythematosus: still not resolved. Semin. Immunopathol. 36, 301-311 (2014).
92. Smeenk, R. J. et al. Anti-dsDNA: choice of assay in relation to clinical value. Rheumatol. Int. 11, 101-107 (1991).
93. Winfield, J. B., Faiferman, I. & Koffler, D. Avidity of anti-DNA antibodies in serum and IgG glomerular eluates from patients with systemic lupus erythematosus. Association of high avidity antinative DNA antibody with glomerulonephritis. J. Clin. Invest. 59, 90-96 (1977).
94. Smeenk, R. & Aarden, L. The use of polyethylene glycol precipitation to detect low-Avidity anti-DNA antibodies in systemic lupus erythematosus. J. Immunol. Methods 39, 165-180 (1980).
95. Isenberg, D. A. Autoantibodies: markers of disease or pathogenic? Ann. N. Y. Acad. Sci. 823, 256-262 (1997).
96. Rose, N. R. & Bona, C. Defining criteria for autoimmune diseases (Witebsky's postulates revisited). Immunol. Today 14, 426-430 (1993).
97. Falkow, S. Molecular Koch's postulates applied to bacterial pathogenicity-A personal recollection 15 years later. Nat. Rev. Microbiol. 2, 67-72 (2004).
98. Izui, S., Lambert, P. H., Fournie, G. J., Turler, H. & Miescher, P. A. Features of systemic lupus erythematosus in mice injected with bacterial lipopolysaccharides: identificantion of circulating DNA and renal localization of DNA-Anti-DNA complexes. J. Exp. Med. 145, 1115-1130 (1977).
99. Mjelle, J. E., Kalaaji, M. & Rekvig, O. P. Exposure of chromatin and not high affinity for dsDNA determines the nephritogenic impact of anti-dsDNA antibodies in (NZB×NZW)F1 mice. Autoimmunity 42, 104-111 (2009).
100. Xie, C., Liang, Z., Chang, S. & Mohan, C. Use of a novel elution regimen reveals the dominance of polyreactive antinuclear autoantibodies in lupus kidneys. Arthritis Rheum. 48, 2343-2352 (2003).
101. Van Bruggen, M. C., Kramers, C., Hylkema, M. N., Smeenk, R. J. & Berden, J. H. Significance of anti-nuclear and anti-extracellular matrix autoantibodies for albuminuria in murine lupus nephritis; a longitudinal study on plasma and glomerular eluates in MRL/l mice. Clin. Exp. Immunol. 105, 132-139 (1996).
102. Yung, S., Cheung, K. F., Zhang, Q. & Chan, T. M. Anti-dsDNA antibodies bind to mesangial annexin II in lupus nephritis. J. Am. Soc. Nephrol. 21, 1912-1927 (2010).
103. Sun, K. H. et al. Anti-dsDNA autoantibody crossreacts with the C-Terminal hydrophobic cluster region containing phenylalanines in the acidic ribosomal phosphoprotein P1 to exert a cytostatic effect on the cells. Biochem. Biophys. Res. Commun. 263, 334-339 (1999).
104. Mjelle, J. E., Rekvig, O. P. & Fenton, K. A. Nucleosomes possess a high affinity for glomerular laminin and collagen IV and bind nephritogenic antibodies in murine lupus-like nephritis. Ann. Rheum. Dis. 66, 1661-1668 (2007).
105. Ehrenstein, M. R. et al. Human IgG anti-DNA antibodies deposit in kidneys and induce proteinuria in SCID mice. Kidney Int. 48, 705-711 (1995).
106. Fenton, K. A., Tommeras, B., Marion, T. N. & Rekvig, O. P. Pure anti-dsDNA mAbs need chromatin structures to promote glomerular mesangial deposits in BALB/c mice. Autoimmunity 43, 179-188 (2009).
107. Adu, D., Dobson, J. & Williams, D. G. DNA-Anti-DNA circulating complexes in the nephritis of systemic lupus erythematosus. Clin. Exp. Immunol. 43, 605-614 (1981).
108. Eilat, D. Crossreactions of anti-DNA antibodies and the central dogma of lupus nephritis. Immunol. Today 6, 123-127 (1985).
109. Fenton, K. et al. Anti-dsDNA antibodies promote initiation, and acquired loss of renal Dnase1 promotes progression of lupus nephritis in autoimmune (NZB×NZW)F1 mice. PLoS ONE 4, e8474 (2009).
110. Kalaaji, M., Sturfelt, G., Mjelle, J. E., Nossent, H. & Rekvig, O. P. Critical comparative analyses of anti-α-Actinin and glomerulus-bound antibodies in human and murine lupus nephritis. Arthritis Rheum. 54, 914-926 (2006).
111. Kalaaji, M., Mortensen, E., Jorgensen, L., Olsen, R. & Rekvig, O. P. Nephritogenic lupus antibodies recognize glomerular basement membrane-Associated chromatin fragments released from apoptotic intraglomerular cells. Am. J. Pathol. 168, 1779-1792 (2006).
112. Kalaaji, M. et al. Glomerular apoptotic nucleosomes are central target structures for nephritogenic antibodies in human SLE nephritis. Kidney Int. 71, 664-672 (2007).
113. Seredkina, N., Zykova, S. N. & Rekvig, O. P. Progression of murine lupus nephritis is linked to acquired renal Dnase1 deficiency and not to upregulated apoptosis. Am. J. Pathol. 175, 97-106 (2009).
114. van der Vlag, J. & Berden, J. H. Lupus nephritis: role of antinucleosome autoantibodies. Semin. Nephrol. 31, 376-389 (2011).
115. LeBlanc, B. A., Urowitz, M. B. & Gladman, O. D. Serologically active, clinically quiescent systemic lupus erythematosus-long-Term follow-up. J. Rheumatol. 21, 174-175 (1994).
116. Gladman, D. D., Urowitz, M. B. & Keystone, E. C. Serologically active clinically quiescent systemic lupus erythematosus: a discordance between clinical and serologic features. Am. J. Med. 66, 210-215 (1979).
117. Grootscholten, C. et al. Deposition of nucleosomal antigens (histones and DNA) in the epidermal basement membrane in human lupus nephritis. Arthritis Rheum. 48, 1355-1362 (2003).
118. Hedberg, A., Fismen, S., Fenton, K. A., Mortensen, E. S. & Rekvig, O. P. Deposition of chromatin-IgG complexes in skin of nephritic MRL-lpr/lpr mice is associated with increased local matrix metalloprotease activities. Exp. Dermatol. 19, e265-e274 (2010).
119. Fismen, S. et al. Circulating chromatin-Anti-chromatin antibody complexes bind with high affinity to dermo-epidermal structures in murine and human lupus nephritis. Lupus 18, 597-607 (2009).
120. Huerta, P. T., Kowal, C., DeGiorgio, L. A., Volpe, B. T. & Diamond, B. Immunity and behaviour: antibodies alter emotion. Proc. Natl Acad. Sci. USA 103, 678-683 (2006).
121. Rajan, T. V. The Gell-Coombs classification of hypersensitivity reactions: a re-interpretation. Trends Immunol. 24, 376-379 (2003).
122. Krishnan, M. R., Jou, N. T. & Marion, T. N. Correlation between the amino acid position of arginine in VH-CDR3 and specificity for native DNA among autoimmune antibodies. J. Immunol. 157, 2430-2439 (1996).